Acute erythroleukemia: Evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics, and prognosis

American Journal of Clinical Pathology

Volumn 110, Issue 5, 1998, Pages 590-598

  Mazzella, Fermina M ^a   Kowal Vern, Areta ^a   Shrit, M Atef ^a   Wibowo, A Luke ^a   Rector, James T ^a   Cotelingam, James D ^a   Collier, Joyce ^a   Mikhael, Anwar ^a   Cualing, Hernani ^a   Schumacher, Harold R ^a  

^a NONE

Author keywords

Cell proliferation; Erythroleukemia; M6a (FAB M6); M6b (pure erythroleukemia)

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; ERYTHROLEUKEMIA; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 0031722539     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/110.5.590     Document Type: Article

References (20)

1. Dameshek W. The DiGuglielmo syndrome revisited. Blood. 1969;34:567-572.
2. Medical Research Council's Committee. The relation between morphology and other features of acute myeloid leukemia, and their prognostic significance. Br J Haematol. 1975;31(suppl):165-180.
3. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukemias. Br J Haematol. 1976;33:451-458.
4. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med. 1985;103:626-629.
5. Cuneo A, Van Orshoven A, Michaux JL, et al. Morphologic, immunologic and cytogenetic studies in erythroleukemia: evidence for multilineage involvement and identification of two distinct cytogenetic-clinicopathological types. Br J Haematol. 1990;75:346-354.
6. Kowal-Vern A, Cotelingam J, Schumacher HR. The prognostic significance of proerythroblasts in acute erythroleukemia. Am J Clin Pathol. 1992;98:34-40.
7. Society for Hematopathology Program. Proposed World Health Organization classification of neoplastic diseases of hematopoietic and lymphoid tissues. Am J Surg Pathol. 1997;21:114-121.
8. Sakurai M, Sandberg AA. Chromosomes and causation of human cancer and leukemia. XI. Correlation of karyotypes with clinical features of acute myeloblastic leukemia. Cancer. 1976;37:285-299.
9. Hsu SM, Cossman J, Jaffe ES. A comparison of ABC, unlabeled antibody, and conjugated immunohistochemical methods with monoclonal and polyclonal antibodies: an examination of germinal center tonsils. Am J Clin Pathol. 1983;80:429-435.
10. Levine EG, Bloomfield CD. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol. 1992;19:47-84.
11. Arky R. Physicians' Desk Reference. 48th ed. Montvale, NJ: Medical Economics Data Production; 1994:673, 688, 825, 1539, 2072-2073.
12. Head DR. Revised classification of acute myeloid leukemia. Leukemia. 1996;10:1826-1831.
13. Williams WJ, Nelson DA. Examination of the marrow. In: Beutler E, Lichtman MA, Collier BS, et al, eds. Williams' Hematology. 5th ed. New York: McGraw-Hill; 1995:15-22.
14. MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res. 1966;26:1189-1200.
15. Schumacher HR. Case 3. In: Acute Leukemia. New York: Igaku-Shoin; 1990:127-135.
16. Beutler E. Hereditary and acquired sideroblastic anemias. In: Beutler E, Lichtman MA, Collier BS, et al, eds. Williams' Hematology. 5th ed. New York: McGraw-Hill; 1995:747-750.
17. Sakurai M, Sandberg AA. Chromosomes and causation of human cancer and leukemia. XIII. An evaluation of karyotypic findings in erythroleukemia. Cancer. 1976;37:790-804.
18. Olopade OI, Thangavelu M, Larson RA, et al. Clinical, morphologic and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood. 1992;80:2873-2882.
19. Nakamura H. Cytogenetic heterogeneity in erythroleukemia defined as M6 by the French-American-British (FAB) cooperative group criteria. Leukemia. 1989;3:305-309.
20. Visani G, Ottaviani E, Danova M, et al. The expression of proliferation and quiescence associated antigens in acute myeloid leukemia correlates with survival duration: analysis of 15 refractory cases. Haematologica. 1997;82:338-340.